AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
1.910
-0.070 (-3.54%)
At close: Aug 29, 2025

AccuStem Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-1.54-1.51-2.05-3.75-0.67-0.09
Depreciation & Amortization
0000--
Stock-Based Compensation
0.390.30.080.130.02-
Other Operating Activities
----0.07--
Change in Accounts Receivable
---1.35--
Change in Accounts Payable
0.120.230.27-0.080.39-
Change in Other Net Operating Assets
0.550.310.090.590.250.09
Operating Cash Flow
-0.49-0.66-1.62-1.81--
Capital Expenditures
----0.01--
Investing Cash Flow
----0.01--
Short-Term Debt Issued
-0.781.25---
Total Debt Issued
0.580.781.25---
Short-Term Debt Repaid
--0.13-0.34-0.34--
Total Debt Repaid
-0.11-0.13-0.34-0.34--
Net Debt Issued (Repaid)
0.470.650.9-0.34--
Issuance of Common Stock
---2.89--
Financing Cash Flow
0.470.650.92.55--
Net Cash Flow
-0.01-0.02-0.710.73--
Free Cash Flow
-0.49-0.66-1.62-1.82--
Free Cash Flow Per Share
-0.04-0.06-0.14-0.17--
Cash Interest Paid
000.010.01--
Levered Free Cash Flow
-0.920.580.11-0.790.26-
Unlevered Free Cash Flow
-0.920.580.11-0.790.26-
Change in Working Capital
0.660.530.351.870.650.09
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.